/Companies

Etheros Pharmaceuticals

Nashville, US · Founded 2022 · Delaware corporation

Find your way into Etheros Pharmaceuticals

Sign up to see every warm intro you have to Etheros Pharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Etheros Pharmaceuticals team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

SCSubhasish Chakraborty
Subhasish ChakrabortyExecutive
JW
John William ScannellExecutive
FK
Francis KnuettelNamed on SEC filing

Board

MF
Marc FeldmannBoard director
FK
Francis Knuettel IIBoard director
LD
Laura DuganBoard director

Reported raises · per SEC filings

Form D private placements

$1.7M disclosed across 3 rounds · 2023–2025

▶$600KraisedJun 2025 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Subhasish ChakrabortyExecutive Officer
  • John William ScannellExecutive Officer, Director
  • Marc FeldmannDirector
  • Francis Knuettel IIDirector
  • Laura DuganDirector
Offering amount
$600K
Amount sold
$600K
Minimum investment
$50K
Proceeds to insiders
$13K
First sale
Jan 2025
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$300KraisedDec 2023 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Subhasish ChakrabortyExecutive Officer
  • John William ScannellExecutive Officer, Director
  • Francis KnuettelDirector
  • Marc FeldmannDirector
  • Laura DuganDirector
Offering amount
$300K
Amount sold
$300K
Minimum investment
$60K
First sale
Nov 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$775KraisedDec 2023 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Subhasish ChakrabortyExecutive Officer
  • John William ScannellExecutive Officer, Director
  • Laura DuganDirector
  • Marc FeldmannDirector
  • Francis KnuettelDirector
Offering amount
$775K
Amount sold
$775K
Minimum investment
$25K
Proceeds to insiders
$350K
First sale
Feb 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Etheros Pharmaceuticals raised?
Etheros Pharmaceuticals has disclosed $1.7M raised across 3 rounds.
Where is Etheros Pharmaceuticals headquartered?
Etheros Pharmaceuticals is headquartered in Nashville, US.